NASDAQ · Biotechnology

Harmony Biosciences Holdings, Inc. (HRMY) Stock

$40.28 +1.72% NASDAQ: HRMY Healthcare

Valuation

MetricValue
Price$40.28
Market Cap$2.33B
P/E Ratio12.66
P/B Ratio2.30
P/S Ratio2.39
EPS (TTM)$2.71
52-Week High$43.49
52-Week Low$25.52
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE20.06%
ROA13.20%
ROCE20.25%
Gross Margin23.96%
Operating Margin23.96%
Net Margin18.88%
Debt/Equity0.15
Current Ratio3.60

Annual Financials (USD)

Metric20212022202320242025
Revenue$305.0M$438.0M$582.0M$715.0M$868.0M
Operating Profit$88.0M$120.0M$192.0M$191.0M$208.0M
Net Profit$35.0M$181.0M$129.0M$145.0M$159.0M
EPS$0.58$2.97$2.13$2.51$2.71
Op Margin28.7%27.4%33.0%26.7%24.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$433.0M$674.0M$811.0M$999.0M$1.3B
Total Liabilities$247.0M$271.0M$344.0M$340.0M$401.0M
Cash$234.0M$244.0M$312.0M$453.0M$753.0M
Borrowings$196.0M$192.0M$194.0M$181.0M$240.0M

Latest News

Deutsche Bank Adjusts Price Target on Harmony Biosciences to $36 From $30, Maintains Hold Rating MT Newswires · Jun 30, 2026 Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation? Zacks · Jun 29, 2026 HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase Zacks · Jun 29, 2026 Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline Zacks · Jun 29, 2026 Harmony Biosciences (HRMY) Stock Valuation After New Pitolisant Data And Reaffirmed Guidance Simply Wall St. · Jun 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$99.0M$144.0M$219.0M$220.0M$348.0M
Investing Cash Flow$-101.0M$-142.0M$-47.0M$-69.0M$-40.0M
Financing Cash Flow$8.0M$9.0M$-104.0M$-2.0M$-3.0M
Net Cash Flow$6.0M$9.0M$67.0M$141.0M$300.0M
Free Cash Flow$98.0M$144.0M$219.0M$219.0M$348.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-10.04
EV / EBITDA6.87
FCF Yield15.46%
Quick Ratio3.45
Interest Coverage17.11
Return 1Y-4.99%
Return 3Y-2.11%
Return 5Y18.45%

Ownership

Insiders Held11.69%
Institutions Held103.37%
Institutions Float Held117.05%
Institutional HolderSharesReport Date
Blackrock Inc.7,070,0352026-03-31
FMR, LLC3,157,6392026-03-31
Vanguard Portfolio Management LLC2,714,3532026-03-31
American Century Companies Inc2,105,1792026-03-31
Vanguard Capital Management LLC2,102,3152026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APMDApnimed, Inc. $18.52 +1.65% 3.69 $737.53M 0.00%
CMPSCOMPASS Pathways plc $13.31 -0.60% -6.19 $1.28B 0.00%
LBRXLB Pharmaceuticals Inc $37.22 +7.54% -12.45 $1.07B 0.00%
NERVMinerva Neurosciences, Inc $3.18 -1.24% -0.12 $148.15M 0.00%

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. (HRMY) stock trades at $40.28 with a market capitalization of $2.33B. The stock is valued at a price-to-earnings (P/E) ratio of 12.66, price-to-book of 2.30, price-to-sales of 2.39. Over the past 52 weeks the stock has ranged between $25.52 and $43.49, and currently trades 7.4% below its 52-week high.

On profitability, Harmony Biosciences Holdings, Inc. generates a return on equity (ROE) of 20.06% — well above the market average, a sign of a high-quality business, return on capital employed of 20.25%, an operating margin of 23.96%, a net profit margin of 18.88%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides